Lifecare to buy 80% stake in Ocean TuniCell for NOK 6 million upfront

• Lifecare agreed to buy 80% of Ocean TuniCell, gaining control of a GMP Grade C cleanroom and production infrastructure in Bergen.
• Closing consideration values Ocean TuniCell at NOK 7.5 million, implying about NOK 6 million for the 80% stake.
• Payment can be cash or newly issued shares; Lifecare plans to settle at closing with shares priced on 15-day VWAP.
• Deal includes up to NOK 6 million contingent consideration tied to a human-use clinical milestone within three years.
• Completion remains subject to third-party consents and final board approval; closing expected promptly once conditions are met.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifecare ASA published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.